MedPath

Gut Microbiota in Obesity and Diabetes

Completed
Conditions
Type 2 Diabetes Mellitus
Obesity
Registration Number
NCT02180191
Lead Sponsor
Gulhane School of Medicine
Brief Summary

An altered gut microbiota composition has recently been linked to obesity and diabetes. The principal aim of this study was to investigate and compare the gut microbiota composition of obese, diabetic and control individuals. Then, associations between analyzed gut microbial concentrations and clinical-biochemical blood parameters were assessed.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
81
Inclusion Criteria
  • Subjects with obesity or newly diagnosed type 2 diabetes
  • 18 years to 65 years of age
Exclusion Criteria
  • Any chronic disease (other than obesity and diabetes)
  • Alcohol consumption/smoking
  • Pregnancy/breastfeeding
  • The use of antibiotics, pro-prebiotics within 3 months
  • <18 years or >65 years
  • History of intestinal surgery

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The comparison of the gut microbiota composition9 months

The gut microbiota composition of obese, diabetic and control individuals was analyzed by quantitative real-time PCR (qRT-PCR)

Secondary Outcome Measures
NameTimeMethod
The relationship between metabolic parameters and the gut microbiota composition9 months

A multivariate linear regression analysis was performed in order to test associations between the gut microbiota composition and metabolic variables of participants

Trial Locations

Locations (1)

Department of Endocrinology and Metabolism, Gulhane School of Medicine

🇹🇷

Ankara, Turkey

Department of Endocrinology and Metabolism, Gulhane School of Medicine
🇹🇷Ankara, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.